Cargando…

Current advances in the selection of adjuvant radiotherapy regimens for keloid

Keloid is a common benign skin tumor in the outpatient department, and patients are often accompanied by itching and pain. Since the pathogenesis is unknown, the effect of single method treatment is unsatisfactory, and therefore the recurrence rate is high. Therefore, comprehensive treatment is most...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Weihao, Zhao, Jiang, Zhang, Chi, Zhang, Wanqi, Jin, Manqiu, Shao, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679021/
https://www.ncbi.nlm.nih.gov/pubmed/36425105
http://dx.doi.org/10.3389/fmed.2022.1043840
_version_ 1784834120455553024
author Wang, Weihao
Zhao, Jiang
Zhang, Chi
Zhang, Wanqi
Jin, Manqiu
Shao, Ying
author_facet Wang, Weihao
Zhao, Jiang
Zhang, Chi
Zhang, Wanqi
Jin, Manqiu
Shao, Ying
author_sort Wang, Weihao
collection PubMed
description Keloid is a common benign skin tumor in the outpatient department, and patients are often accompanied by itching and pain. Since the pathogenesis is unknown, the effect of single method treatment is unsatisfactory, and therefore the recurrence rate is high. Therefore, comprehensive treatment is mostly used in clinical treatment. Adjuvant radiotherapy is currently one of the most effective treatments for keloid. After long-term clinical practice, brachytherapy and electron beam radiotherapy has increasingly become the gold standard of treatment, because brachytherapy provides more focused radiation treatment to focal tissue to significantly reduce recurrence rate, and better preserve normal tissue. With the development of new radiotherapy techniques, more options for the treatment of keloid. Currently, adjuvant radiotherapy has been widely recognized, but there is no consensus on the optimal protocol for adjuvant radiotherapy for keloids. This review provides a review of published treatment options and new radiotherapy techniques for adjuvant radiotherapy of keloids and gives a comprehensive evaluation for clinical treatment.
format Online
Article
Text
id pubmed-9679021
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-96790212022-11-23 Current advances in the selection of adjuvant radiotherapy regimens for keloid Wang, Weihao Zhao, Jiang Zhang, Chi Zhang, Wanqi Jin, Manqiu Shao, Ying Front Med (Lausanne) Medicine Keloid is a common benign skin tumor in the outpatient department, and patients are often accompanied by itching and pain. Since the pathogenesis is unknown, the effect of single method treatment is unsatisfactory, and therefore the recurrence rate is high. Therefore, comprehensive treatment is mostly used in clinical treatment. Adjuvant radiotherapy is currently one of the most effective treatments for keloid. After long-term clinical practice, brachytherapy and electron beam radiotherapy has increasingly become the gold standard of treatment, because brachytherapy provides more focused radiation treatment to focal tissue to significantly reduce recurrence rate, and better preserve normal tissue. With the development of new radiotherapy techniques, more options for the treatment of keloid. Currently, adjuvant radiotherapy has been widely recognized, but there is no consensus on the optimal protocol for adjuvant radiotherapy for keloids. This review provides a review of published treatment options and new radiotherapy techniques for adjuvant radiotherapy of keloids and gives a comprehensive evaluation for clinical treatment. Frontiers Media S.A. 2022-11-08 /pmc/articles/PMC9679021/ /pubmed/36425105 http://dx.doi.org/10.3389/fmed.2022.1043840 Text en Copyright © 2022 Wang, Zhao, Zhang, Zhang, Jin and Shao. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Wang, Weihao
Zhao, Jiang
Zhang, Chi
Zhang, Wanqi
Jin, Manqiu
Shao, Ying
Current advances in the selection of adjuvant radiotherapy regimens for keloid
title Current advances in the selection of adjuvant radiotherapy regimens for keloid
title_full Current advances in the selection of adjuvant radiotherapy regimens for keloid
title_fullStr Current advances in the selection of adjuvant radiotherapy regimens for keloid
title_full_unstemmed Current advances in the selection of adjuvant radiotherapy regimens for keloid
title_short Current advances in the selection of adjuvant radiotherapy regimens for keloid
title_sort current advances in the selection of adjuvant radiotherapy regimens for keloid
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679021/
https://www.ncbi.nlm.nih.gov/pubmed/36425105
http://dx.doi.org/10.3389/fmed.2022.1043840
work_keys_str_mv AT wangweihao currentadvancesintheselectionofadjuvantradiotherapyregimensforkeloid
AT zhaojiang currentadvancesintheselectionofadjuvantradiotherapyregimensforkeloid
AT zhangchi currentadvancesintheselectionofadjuvantradiotherapyregimensforkeloid
AT zhangwanqi currentadvancesintheselectionofadjuvantradiotherapyregimensforkeloid
AT jinmanqiu currentadvancesintheselectionofadjuvantradiotherapyregimensforkeloid
AT shaoying currentadvancesintheselectionofadjuvantradiotherapyregimensforkeloid